Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spinetronics is a private healthcare and medical device company focused on non-surgical spinal decompression systems for musculoskeletal and spine-related pain management. Its flagship commercial product is Antalgic-Trak, an articulating cervical and lumbar spinal decompression system used by chiropractors, physical therapists, osteopaths, and other spine specialists. The company positions its technology around multi-axis, posture-adjustable decompression intended to address neck and back conditions such as herniated discs, sciatica, spinal stenosis, and degenerative joint disease. Spinetronics appears to operate as a small commercial-stage device business rather than a drug-development biotech company, with activity centered on product sales, practitioner training, and therapy marketing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spinetronics.